Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

1. A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

   Journal Article

   Rathkopf, D.; Wong, B. Y.; Ross, R. W.; Anand, A.; Tanaka, E.; Woo, M. M.; Hu, J.; Dzik-Jurasz, A.; Yang, W.; Scher, H. I.
   Cancer Chemotherapy and Pharmacology (2010)

   Fulltext@MSK | Save
2. A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)

   Meeting Abstract

   Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Tanaka, E.; Chen, Y.; Atadja, P.; Yang, W.; Culver, K. W.; more...
   Journal of Clinical Oncology (2008)

   Fulltext@MSK | Save
3. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer

   Journal Article

   Danila, D. C.; Heller, G.; Gignac, G. A.; Gonzalez-Espinoza, R.; Anand, A.; Tanaka, E.; Lilja, H.; Schwartz, L.; Larson, S.; Fleisher, M.; more...
   Clinical Cancer Research (2007)

   Fulltext@MSK | Save